Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up study of brivaracetam adjunctive treatment in epilepsy
NL-OMON41449Phase 3Active, not recruiting
- Sponsor
- UCB
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, Focal Onset Epilepsy, sponsored by UCB. Started May 2011; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on NL-OMON41449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41449.